NYSE:OSTX OS Therapies (OSTX) Stock Price, News & Analysis $4.70 -0.46 (-8.91%) (As of 05:27 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends About OS Therapies Stock (NYSE:OSTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OS Therapies alerts:Sign Up Key Stats Today's Range$4.38▼$5.9350-Day Range$1.74▼$5.1652-Week Range$1.58▼$6.48Volume76,863 shsAverage Volume127,811 shsMarket Capitalization$99.82 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingStrong Buy Company OverviewOS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.Read More… Receive OSTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address OSTX Stock News HeadlinesOS Therapies Partners with B2i Digital to Engage with Biotech Investors OnlineDecember 26, 2024 | businesswire.comOS Therapies to sell 1.5M units at $4.00 in private placementDecember 25, 2024 | finance.yahoo.comKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years. I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks. December 30, 2024 | Porter & Company (Ad)OS Therapies Prices Private Placement Of 1.5 Mln Units At $4/Unit, Stock RisesDecember 24, 2024 | markets.businessinsider.comOS Therapies Announces Pricing of $6 Million Private PlacementDecember 24, 2024 | businesswire.comMaxim Group Initiates Coverage of OS Therapies (OSTX) with Buy RecommendationNovember 27, 2024 | msn.comOS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | businesswire.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 15, 2024 | investorplace.comSee More Headlines OSTX Stock Analysis - Frequently Asked Questions How have OSTX shares performed this year? OS Therapies' stock was trading at $4.00 on January 1st, 2024. Since then, OSTX shares have increased by 17.5% and is now trading at $4.70. View the best growth stocks for 2024 here. When did OS Therapies IPO? OS Therapies (OSTX) raised $8 million in an initial public offering (IPO) on Thursday, August 1st 2024. The company issued 2,000,000 shares at $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) served as the underwriter for the IPO. When does the company's lock-up period expire? OS Therapies' lock-up period expires on Tuesday, January 28th. OS Therapies had issued 1,600,000 shares in its public offering on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company. How do I buy shares of OS Therapies? Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of OS Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX). Company Calendar Today12/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSE:OSTX Previous SymbolNYSE:OSTX CUSIPN/A CIK1795091 WebN/A Phone(410) 297-7793FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+51.5%Consensus RatingStrong Buy Rating Score (0-4)3.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,790,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-569.57% Debt Debt-to-Equity RatioN/A Current Ratio0.76 Quick Ratio0.76 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares21,238,000Free FloatN/AMarket Cap$112.14 million OptionableN/A BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:OSTX) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OS Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share OS Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
